ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

Late Effects In Breast Cancer Treatment Found In Study

January 25, 2002

Advisors seek support for NCI’s “special authorities” granted in 1971.

July 15, 2005

Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs

July 29, 1983

Werner Kirsten, director, Fredrick Center, Dead At 67 of Heart Attack

January 1, 1993

Army Accepting Letters of Intent For Research in Breast Cancer; Plans Announcement In Sept.

July 16, 1993